Biography and Research Information
OverviewAI-generated summary
Wuying Du's research investigates the molecular mechanisms underlying disease progression and potential therapeutic interventions. Du has published work on the role of SIRT2 in promoting melanoma progression through the inhibition of natural killer cells, as well as its potential involvement in alleviating cisplatin-induced peripheral neuropathy. Further research includes studies on synergistic effects of IFNγ and antibodies in enhancing protective immunity against Chlamydia dissemination and female reproductive tract reinfections. Collaborations include work with Lin‐Xi Li, Miguel A. B. Mercado, Priyangi A. Malaviarachchi, and Mousumi Patra, all from the University of Arkansas for Medical Sciences, with whom Du has co-authored multiple publications. Du's scholarly output includes 14 publications with a total of 306 citations and an h-index of 7.
Metrics
- h-index: 7
- Publications: 14
- Citations: 309
Selected Publications
-
IFNγ and Antibody Synergize To Enhance Protective Immunity against Chlamydia Dissemination and Female Reproductive Tract Reinfections (2022)
-
IFNγ and antibody synergize to enhance protective immunity against <i>Chlamydia</i> dissemination and female reproductive tract reinfections (2022)
-
Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation (2022)
-
SIRT2 promotes murine melanoma progression through natural killer cell inhibition (2021)
Collaboration Network
Top Collaborators
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- IFNγ and Antibody Synergize To Enhance Protective Immunity against Chlamydia Dissemination and Female Reproductive Tract Reinfections
- IFNγ and antibody synergize to enhance protective immunity against <i>Chlamydia</i> dissemination and female reproductive tract reinfections
- IFNγ and Antibody Synergize To Enhance Protective Immunity against Chlamydia Dissemination and Female Reproductive Tract Reinfections
- IFNγ and antibody synergize to enhance protective immunity against <i>Chlamydia</i> dissemination and female reproductive tract reinfections
- IFNγ and Antibody Synergize To Enhance Protective Immunity against Chlamydia Dissemination and Female Reproductive Tract Reinfections
- IFNγ and antibody synergize to enhance protective immunity against <i>Chlamydia</i> dissemination and female reproductive tract reinfections
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
- IFNγ and antibody synergize to enhance protective immunity against <i>Chlamydia</i> dissemination and female reproductive tract reinfections
- IFNγ and Antibody Synergize To Enhance Protective Immunity against Chlamydia Dissemination and Female Reproductive Tract Reinfections
Similar Researchers
Based on overlapping research topics